nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—ABCB1—peripheral nervous system neoplasm	0.403	1	CbGaD
Loratadine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0612	0.144	CbGbCtD
Loratadine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0446	0.105	CbGbCtD
Loratadine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0446	0.105	CbGbCtD
Loratadine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0427	0.1	CbGbCtD
Loratadine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0309	0.0726	CbGbCtD
Loratadine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0267	0.0627	CbGbCtD
Loratadine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0258	0.0605	CbGbCtD
Loratadine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0248	0.0583	CbGbCtD
Loratadine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.019	0.0447	CbGbCtD
Loratadine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0183	0.0429	CbGbCtD
Loratadine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0177	0.0417	CbGbCtD
Loratadine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0174	0.0409	CbGbCtD
Loratadine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0119	0.0279	CbGbCtD
Loratadine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0114	0.0268	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0112	0.0263	CbGbCtD
Loratadine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0104	0.0245	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00712	0.0167	CbGbCtD
Loratadine—Desloratadine—ABCB1—peripheral nervous system neoplasm	0.000751	1	CrCbGaD
Loratadine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000327	0.00192	CcSEcCtD
Loratadine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000323	0.0019	CcSEcCtD
Loratadine—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000321	0.00189	CcSEcCtD
Loratadine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000321	0.00189	CcSEcCtD
Loratadine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000321	0.00189	CcSEcCtD
Loratadine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00032	0.00188	CcSEcCtD
Loratadine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000319	0.00188	CcSEcCtD
Loratadine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000317	0.00187	CcSEcCtD
Loratadine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000317	0.00186	CcSEcCtD
Loratadine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000317	0.00186	CcSEcCtD
Loratadine—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000316	0.00186	CcSEcCtD
Loratadine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000315	0.00185	CcSEcCtD
Loratadine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000313	0.00184	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00182	CcSEcCtD
Loratadine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000308	0.00181	CcSEcCtD
Loratadine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000308	0.00181	CcSEcCtD
Loratadine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000307	0.0018	CcSEcCtD
Loratadine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000306	0.0018	CcSEcCtD
Loratadine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000306	0.0018	CcSEcCtD
Loratadine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000305	0.0018	CcSEcCtD
Loratadine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000304	0.00179	CcSEcCtD
Loratadine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000302	0.00178	CcSEcCtD
Loratadine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.00177	CcSEcCtD
Loratadine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000301	0.00177	CcSEcCtD
Loratadine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000301	0.00177	CcSEcCtD
Loratadine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000301	0.00177	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000299	0.00176	CcSEcCtD
Loratadine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000299	0.00176	CcSEcCtD
Loratadine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.00175	CcSEcCtD
Loratadine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000298	0.00175	CcSEcCtD
Loratadine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000298	0.00175	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000298	0.00175	CcSEcCtD
Loratadine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.00175	CcSEcCtD
Loratadine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000296	0.00174	CcSEcCtD
Loratadine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000296	0.00174	CcSEcCtD
Loratadine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000295	0.00174	CcSEcCtD
Loratadine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000293	0.00173	CcSEcCtD
Loratadine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.00172	CcSEcCtD
Loratadine—Malaise—Etoposide—peripheral nervous system neoplasm	0.000292	0.00172	CcSEcCtD
Loratadine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00172	CcSEcCtD
Loratadine—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.00172	CcSEcCtD
Loratadine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.0017	CcSEcCtD
Loratadine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00029	0.0017	CcSEcCtD
Loratadine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000289	0.0017	CcSEcCtD
Loratadine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000289	0.0017	CcSEcCtD
Loratadine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000289	0.0017	CcSEcCtD
Loratadine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000287	0.00169	CcSEcCtD
Loratadine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000285	0.00168	CcSEcCtD
Loratadine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.00168	CcSEcCtD
Loratadine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000284	0.00167	CcSEcCtD
Loratadine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000284	0.00167	CcSEcCtD
Loratadine—Rash—Topotecan—peripheral nervous system neoplasm	0.000284	0.00167	CcSEcCtD
Loratadine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000284	0.00167	CcSEcCtD
Loratadine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000283	0.00167	CcSEcCtD
Loratadine—Cough—Etoposide—peripheral nervous system neoplasm	0.000283	0.00166	CcSEcCtD
Loratadine—Headache—Topotecan—peripheral nervous system neoplasm	0.000282	0.00166	CcSEcCtD
Loratadine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000282	0.00166	CcSEcCtD
Loratadine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000282	0.00166	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000282	0.00166	CcSEcCtD
Loratadine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00166	CcSEcCtD
Loratadine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000282	0.00166	CcSEcCtD
Loratadine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000282	0.00166	CcSEcCtD
Loratadine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000282	0.00166	CcSEcCtD
Loratadine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000281	0.00165	CcSEcCtD
Loratadine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00028	0.00165	CcSEcCtD
Loratadine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00028	0.00165	CcSEcCtD
Loratadine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00028	0.00165	CcSEcCtD
Loratadine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00028	0.00165	CcSEcCtD
Loratadine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.00164	CcSEcCtD
Loratadine—Pain—Vincristine—peripheral nervous system neoplasm	0.000279	0.00164	CcSEcCtD
Loratadine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000279	0.00164	CcSEcCtD
Loratadine—Rash—Melphalan—peripheral nervous system neoplasm	0.000278	0.00164	CcSEcCtD
Loratadine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000278	0.00164	CcSEcCtD
Loratadine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.00163	CcSEcCtD
Loratadine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000276	0.00162	CcSEcCtD
Loratadine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000276	0.00162	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000274	0.00161	CcSEcCtD
Loratadine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000273	0.0016	CcSEcCtD
Loratadine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00027	0.00159	CcSEcCtD
Loratadine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.00158	CcSEcCtD
Loratadine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.00158	CcSEcCtD
Loratadine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000268	0.00158	CcSEcCtD
Loratadine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000267	0.00157	CcSEcCtD
Loratadine—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000267	0.00157	CcSEcCtD
Loratadine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000266	0.00156	CcSEcCtD
Loratadine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000266	0.00156	CcSEcCtD
Loratadine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000265	0.00156	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000263	0.00155	CcSEcCtD
Loratadine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000262	0.00154	CcSEcCtD
Loratadine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000262	0.00154	CcSEcCtD
Loratadine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000259	0.00153	CcSEcCtD
Loratadine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000258	0.00152	CcSEcCtD
Loratadine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000258	0.00152	CcSEcCtD
Loratadine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000258	0.00152	CcSEcCtD
Loratadine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000257	0.00151	CcSEcCtD
Loratadine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.0015	CcSEcCtD
Loratadine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00025	0.00147	CcSEcCtD
Loratadine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000249	0.00147	CcSEcCtD
Loratadine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000247	0.00145	CcSEcCtD
Loratadine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.00145	CcSEcCtD
Loratadine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000247	0.00145	CcSEcCtD
Loratadine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000243	0.00143	CcSEcCtD
Loratadine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000241	0.00142	CcSEcCtD
Loratadine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000238	0.0014	CcSEcCtD
Loratadine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000238	0.0014	CcSEcCtD
Loratadine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000235	0.00138	CcSEcCtD
Loratadine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000234	0.00138	CcSEcCtD
Loratadine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000233	0.00137	CcSEcCtD
Loratadine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000232	0.00137	CcSEcCtD
Loratadine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.00136	CcSEcCtD
Loratadine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00023	0.00136	CcSEcCtD
Loratadine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000228	0.00134	CcSEcCtD
Loratadine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000228	0.00134	CcSEcCtD
Loratadine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000228	0.00134	CcSEcCtD
Loratadine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000226	0.00133	CcSEcCtD
Loratadine—Pain—Etoposide—peripheral nervous system neoplasm	0.000226	0.00133	CcSEcCtD
Loratadine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.00132	CcSEcCtD
Loratadine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000223	0.00131	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00131	CcSEcCtD
Loratadine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00022	0.00129	CcSEcCtD
Loratadine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000219	0.00129	CcSEcCtD
Loratadine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000218	0.00128	CcSEcCtD
Loratadine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000217	0.00128	CcSEcCtD
Loratadine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000216	0.00127	CcSEcCtD
Loratadine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000216	0.00127	CcSEcCtD
Loratadine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.00127	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.00127	CcSEcCtD
Loratadine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.00126	CcSEcCtD
Loratadine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00126	CcSEcCtD
Loratadine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.00125	CcSEcCtD
Loratadine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000209	0.00123	CcSEcCtD
Loratadine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000209	0.00123	CcSEcCtD
Loratadine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000208	0.00122	CcSEcCtD
Loratadine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000207	0.00122	CcSEcCtD
Loratadine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000207	0.00122	CcSEcCtD
Loratadine—Rash—Vincristine—peripheral nervous system neoplasm	0.000206	0.00121	CcSEcCtD
Loratadine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000206	0.00121	CcSEcCtD
Loratadine—Headache—Vincristine—peripheral nervous system neoplasm	0.000205	0.0012	CcSEcCtD
Loratadine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.0012	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00119	CcSEcCtD
Loratadine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.00118	CcSEcCtD
Loratadine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000198	0.00116	CcSEcCtD
Loratadine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00114	CcSEcCtD
Loratadine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000194	0.00114	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.00113	CcSEcCtD
Loratadine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00019	0.00112	CcSEcCtD
Loratadine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000189	0.00111	CcSEcCtD
Loratadine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000186	0.0011	CcSEcCtD
Loratadine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00109	CcSEcCtD
Loratadine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000184	0.00108	CcSEcCtD
Loratadine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000182	0.00107	CcSEcCtD
Loratadine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000182	0.00107	CcSEcCtD
Loratadine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000181	0.00106	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00106	CcSEcCtD
Loratadine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000178	0.00105	CcSEcCtD
Loratadine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000178	0.00105	CcSEcCtD
Loratadine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000176	0.00104	CcSEcCtD
Loratadine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000175	0.00103	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00103	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.00101	CcSEcCtD
Loratadine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000172	0.00101	CcSEcCtD
Loratadine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.001	CcSEcCtD
Loratadine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000992	CcSEcCtD
Loratadine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000168	0.000989	CcSEcCtD
Loratadine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000982	CcSEcCtD
Loratadine—Rash—Etoposide—peripheral nervous system neoplasm	0.000167	0.000981	CcSEcCtD
Loratadine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000167	0.00098	CcSEcCtD
Loratadine—Headache—Etoposide—peripheral nervous system neoplasm	0.000166	0.000975	CcSEcCtD
Loratadine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000971	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000969	CcSEcCtD
Loratadine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000964	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000961	CcSEcCtD
Loratadine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000959	CcSEcCtD
Loratadine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000945	CcSEcCtD
Loratadine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000939	CcSEcCtD
Loratadine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000933	CcSEcCtD
Loratadine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000157	0.000924	CcSEcCtD
Loratadine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000923	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000918	CcSEcCtD
Loratadine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00091	CcSEcCtD
Loratadine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00091	CcSEcCtD
Loratadine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000909	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000904	CcSEcCtD
Loratadine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000899	CcSEcCtD
Loratadine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000892	CcSEcCtD
Loratadine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00089	CcSEcCtD
Loratadine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000887	CcSEcCtD
Loratadine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000874	CcSEcCtD
Loratadine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000872	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000869	CcSEcCtD
Loratadine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000863	CcSEcCtD
Loratadine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000858	CcSEcCtD
Loratadine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000856	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000854	CcSEcCtD
Loratadine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000851	CcSEcCtD
Loratadine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000847	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000842	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000842	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000836	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000832	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000823	CcSEcCtD
Loratadine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000815	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000807	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000795	CcSEcCtD
Loratadine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000794	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000792	CcSEcCtD
Loratadine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000789	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000788	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000784	CcSEcCtD
Loratadine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000783	CcSEcCtD
Loratadine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000776	CcSEcCtD
Loratadine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000768	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000754	CcSEcCtD
Loratadine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000753	CcSEcCtD
Loratadine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000752	CcSEcCtD
Loratadine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000746	CcSEcCtD
Loratadine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000746	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000735	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00073	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000725	CcSEcCtD
Loratadine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000719	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000718	CcSEcCtD
Loratadine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000713	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000711	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000697	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000696	CcSEcCtD
Loratadine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00069	CcSEcCtD
Loratadine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00069	CcSEcCtD
Loratadine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00069	CcSEcCtD
Loratadine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00069	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000665	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00066	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000638	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000638	CcSEcCtD
Loratadine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000626	CcSEcCtD
Loratadine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000597	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	0.000579	CcSEcCtD
Loratadine—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.81e-05	0.000577	CcSEcCtD
Loratadine—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.43e-05	0.000555	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.000552	CcSEcCtD
Loratadine—Rash—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.00055	CcSEcCtD
Loratadine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.00055	CcSEcCtD
Loratadine—Headache—Epirubicin—peripheral nervous system neoplasm	9.29e-05	0.000547	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000534	CcSEcCtD
Loratadine—Nausea—Epirubicin—peripheral nervous system neoplasm	8.81e-05	0.000518	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000513	CcSEcCtD
Loratadine—Rash—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000509	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.000508	CcSEcCtD
Loratadine—Headache—Doxorubicin—peripheral nervous system neoplasm	8.6e-05	0.000506	CcSEcCtD
Loratadine—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.000479	CcSEcCtD
